跳至主要内容
临床试验/ACTRN12611000146998
ACTRN12611000146998招募中未知

Predictors of Response to Therapy in New-Presentation Idiopathic Dilated Cardiomyopathy

Professor Joseph Selvanayagam0 个研究点目标入组 200 人开始时间: 2011年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Clinical heart failure (New York Heart Association class II - IV) on first presentation, LV ejection fraction <45% as measured by echocardiography, ventriculography, or cardiac
  • scintigraphy

排除标准

  • Standard MRI contraindications, including permanent pacemaker, implantable defibrillator,
  • severe claustrophobia, Significant coronary artery disease, as manifest by >70% stenosis in a major epicardial
  • coronary artery or the presence of a moderate or greater zone of ischaemia/infarction on
  • stress imaging, Concomitant valvular heart disease as a cause or central contributor to the heart failure
  • (excluding functional mitral regurgitation, Hypertrophic obstructive cardiomyopathy, Myocarditis, amyloidosis, sarcoidosis, uncontrolled thyroid disease, post-partum
  • cardiomyopathy, Renal impairment (eGFR <60ml/min) will be an exclusion criterion from the administration
  • of gadolinium, New York Heart Association class IV symptoms (i.e. dyspnoea at rest), and unstable
  • ischaemic heart disease will be exclusion criteria from cardiopulmonary exercise testing

研究者

发起方
Professor Joseph Selvanayagam

相似试验